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The maintenance of extracellular fluid volume within a narrow range 
is an essential prerequisite for establishing Claude Bernard's "constancy 
of internal milieu" within the human organism. As a predominant solute 
of ECF, sodium salts represent the major determinant of this volume. 
Hence, an appreciation of the metabolism of sodium under normal physiologic 
circumstances is of utmost importance in understanding normal sodium 
homeostasis as we 11 as the pathophysiology of the various salt-retaining, 
or edematous, states. 
Aside from the absorption or loss of sodium by way of the gastro¬ 
intestinal tract or skin, the kidney represents the major site of sodium 
conservation. Here, as a consequence of relatively subtle changes in 
extracellular volume (under normal conditions), sodium is either reabsorbed 
or excreted in an attempt to preserve the normal volume of this fluid 
compartment. The amount of sodium excreted depends on the difference 
between the amount filtered by the glomeruli, and that reabsorbed by the 
tubules. Clearly, alteration of either parameter will have pronounced 
effects on the quantity of sodium excreted in the urine. This relation 
has been known for several decades. However, what remains obscure at the 
present time are the following: (I) The manner in which the kidney 
perceives subtle changes In extracellular fluid volume and (2) the trans¬ 
lation of these signals into various renal mechanisms operative in 
altering sodium excretion. 
Prior to 1961, it was generally felt that control over sodium 
excretion by the kidney was the resultant of two major events or "factors": 
glomerular filtration and the sodium reabsorptive effect of aldosterone. 
It was recognized then, as now, however, that mere alterations in GFR do 
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not bring about proportional changes in sodium excretion. At the 
proximal tubular level, the phenomenon of glomerulotubular balance is 
operative. Nonetheless, the rate of glomerular filtration can play a 
major role in the absolute excretion of sodium for a given rate of tubular 
reabsorption [1], In addition, the ability of aldosterone to facilitate 
sodium reabsorption at the distal tubular level has long been acknowledged. 
De V'ardner [2] demonstrated in 1961 , however, that the above two 
factors did not operate alone in controlling sodium metabolism. During 
an infusion of saline in mineralocorticoid-treated dogs, the abdominal 
aorta was constricted above the take-off of the renal arteries, thereby 
diminishing renal blood flow and glomerular filtration. Unexpectedly, 
sodium excretion persisted despite a decrease In GFR and high levels of 
DOCA. These results were confirmed in several laboratories. The 
conclusion to be drawn was that other non-a1dersterone factors influenced 
the tubular reabsorption of sodium. Several of these factors have been 
subsequently elucidated [1,3,^]. They included: peritubular oncotic and 
hydrostatic pressure; intrarenal redistribution of blood flow to nephron 
populations of differing reabsorptive capacities; and a postulated 
natriuretic hormone. Together, these hormonal and hemodynamic variables 
influencing sodium reabsorption encompass what the literature has referred 
to as the "third factor." 
A discussion of filtration fraction serves to illustrate the 
importance of "third factor." By definition, this is a ratio of GFR to 
RBF, and may be regarded as an index of the relation between glomerular 
filtration and post glomerular hydrostatic pressure. With saline infusion, 
there is a decrease in renal vascular resistance and a concomitant decrease 
in filtration fraction (FF). As a consequence, peritubular hydrostatic 
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pressure is elevated, and sodium reabsorption (luminal to peritubular) 
depressed. Conversely, in a hypovolemic situation, if perfusion pressure 
fa 11s--but to a degree not sufficient to decrease GFR--the FF will rise. 
Peritubular hydrostatic pressure declines and sodium reabsorption is 
enhanced. 
The importance of these peritubular forces has recently been 
emphasized in a paper by Giebish [5]. Indeed, the phenomenon of glomeru¬ 
lotubular balance Is in all probability a resultant of these intrarenal, 
third factor mechanisms. But as mentioned previously, the manner in which 
the kidney perceives changes in ECF volume and translates such information 
into alterations of GFR, aldosterone secretion, and third factor--so as 
to effect changes in sodium reabsorption--remaI ns undefined. However, 
much evidence has been adduced implicating a significant role for the 
sympathetic nervous system in this process. Herein lies the stimulus 
for the undertaking of this thesis. 
The remainder of the introduction will be devoted to demonstrating 
the role played by the sympathetic nervous activity in renal sodium 
metabolism. in so doing, a firm experimenta1-theoretica1 foundation 
will hopefully be constructed, from which the justification for my thesis 
and conclusions drawn therefrom should be evident. 
From a gross anatomic standpoint, the kidney receives autonomic 
postganglionic fibers from the celiac and superior mesenteric ganglia. 
Preganglionic fibers are derived from the splanchnic nerves. At a finer 
level, various workers have described sympathetic innervation to afferent 
and efferent arterioles, venules, and vasa recta [6,7,8]. 
A study performed by ljungqvist [9], comparing rat to human 
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neurovasculature, revealed the importance of correlating renal innervation 
and vascular anatomy with function. In both species cortical arteriolar 
continuity is interrupted by glomerular tufts. In fact, the tufts constitute 
the only connection between afferent and efferent vessels. (Efferent 
arterioles later subdivide to form a peritubular capillary plexus.) In 
contrast to this, arterioles within the juxtamedu11 ary zone are continuous 
vessels leading to the medulla. Here, glomerular tufts are elaborated as 
side branches of this vessel; and afferent and efferent arterioles are In 
anatomic continuity at the vascular pedicle of the tuft. In this study, 
Ljungqvist demonstrated, by fluorescence microscopy, adrenergic innervations 
along afferent and efferent vessels at both cortical and juxtamedu11 ary 
levels. 
The physiologic consequence of this vascular architecture with its 
autonomic associations are evident (9]: Increased adrenergic activity 
at the juxtamedu1lary level with resulting vasoconstriction here, should 
reduce the capacity of these extraa1omeru1ar medullary pathways and shunt 
renal blood flow to the cortex. Here, no ext rag 1omerular routes are 
available and GFR would increase, thereby augmenting filtration fraction 
and net sodium reabsorption (third factor effects). 
Much evidence has been advanced to suggest an active "in vivo" role 
of the sympathetic nervous system in the control of renal vasomotion and 
sodium balance. Zimmerman et al. [10] stimulated the renal nerves of 
healthy mongrel dogs. This produces marked vasoconstriction and a 
concomitant release of catecholamine (norepinephrine) in the venous 
effluent. Concha [11] cannulated the artery and vein of the left kidney 
of a dog, leaving the renal nerves intact. (Perfusate was Tyrode's solution.) 
He noted that renal vasoconstriction was consistently evoked by stimulation 
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of the left major splanchnic nerve. Mo vasomotion was produced by 
excitation of the subdiaphragmatic vagi. In another interesting experiment, 
he collected the perfusate following nervous stimulation and re-injected 
it into the kidney. Vasoconstriction was subsequently elicited. No such 
effect was demonstrated v/ith perfusate from a non-st imu 1 ated kidney or 
saline control. These results suggested that vasoconstriction was 
associated with the release of a vasoconstrictor substance following 
nervous stimulation. Direct infusion of norepinephrine (0.0001 /jg/ml) 
provided strong vasoconstriction. Finally, the ability of Hydergine 
(dihydroergotoxine mesylate), and o^-adrenergic antagonist, to block the 
vasoconstrictive response to renal nerve stimulation, suggested the 
adrenergic nature of renal innervation. All these results are consistent 
with the hypothesis that renal innervation is chiefly adrenergic, and 
that sympathetic activity plays a role in vasomotion here. 
Clearly, sympathetic nervous input to the kidney does not operate in 
a vacuum. On the contrary, it is one manifestation of overall sympathetic 
discharge resulting from such stimuli as hypovolemia, excitement, hypo¬ 
glycemia, etc.; and it participates in concert with other sympathetically 
innervated structures to restore the organism to a state of equilibrium. 
The relationship of renal nerve activity to hypothalamic activity and the 
baroreceptor ref 1ex--both preeminent modulators of sympathetic activity-- 
serves to illustrate this point. Having performed bilateral carotid 
occlusion on dogs, iriuchijima [12] demonstrated an increase in mean renal 
nerve activity. Similar results are obtained by sectioning of baroreceptor 
afferent nerves [133- In a study on lightly anesthetized cats, V/ilson 
et al. portrayed mean renal nerve activity as a “linear combination of 
hypothalamic, basal central neural (medullary or supramedu11 ary), and 
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baroreceptor reflex activity" [1^]. 
A more clinically related experiment--and perhaps more provocative-- 
was performed by Gill and Casper [15], when they investigated the role of 
the sympathetic nervous system in the renal response to hemorrhage. 
Hemorrhage, of course, calls forth an increase in sympathetic activity 
secondary to the baroreceptor reflex. And, as demonstrated above, this 
adrenergic activity is transmitted to the kidneys and manifested as 
alterations in RBF, GFR and sodium excretion. In this experiment a DOCA- 
treated canine donor was used to perfuse (by cross-circulation techniques) 
the kidney of a DOCA-treated recipient (dog) whose renal nerve supply 
was left intact. At all times throughout the experiment, the mean arterial 
pressure in donor and recipient kidneys was constant and equal. A 
natriuresis was induced in both donor and recipient kidneys by saline- 
albumin infusion in the donor. Then, the recipient animal was bled so as 
to elicit marked sympathetic activity to the perfused kidney--which was 
otherwise protected from the other changes accompanying hypovolemia. The 
results were striking: sodium excretion in the perfused recipient kidney 
was reduced by 50 per cent, without significant change in sodium output 
of the donor. This diminution In sodium excretion occurred despite 
continued exposure of the perfused kidney to such natriuretic stimuli 
(arising from the donor circulation) as hemodi1ution, natriuretic hormone, 
etc.--all of which would otherwise oppose sodium conservation. Furthermore, 
when the sympathetic nerve supply to the perfused kidney was interrupted, 
there was no change in sodium excretion in response to hemorrhage--even 
with a ^2 per cent decrease in mean arterial pressure in the recipient. 
Hence we are provided with "prima facie" evidence that the sympathetic 




Several other studies have implicated the adrenergic nervous system 
in renal sodium metabolism. In man, it has been shown that sympathetic 
blockade with guanethidine impaired sodium conservation during periods of 
sodium deprivation [16]. There have been several case reports of impaired 
ability to reabsorb sodium in patients with insufficiency of the autonomic 
nervous system [17]• Finally, it has been pointed out that adrenergic 
blockade facilitates sodium excretion in normal subjects administered 
saline infusion or treated with mineralocort?coids [18]. 
The actual mechanism(s) by which sympathetic nervous activity effects 
alterations in sodium balance has only been alluded to so far, vis-a-vis 
Ijungqvlst's correlation of renal vascular and neural architecture. In 
19^7, Trueta, et al. [19], provided some insight into this problem by 
demonstrating reductions in cortical blood flow--with maintenance of 
medullary f1ow--during periods of shock in dogs. Since these observations, 
much effort has been directed toward ascribing an active role for the 
sympathetic nervous system in the intrarenal redistribution of blood flow. 
More clinically related research topics have included the association of 
this phenomenon with hypovolemia, sodium deprivation, or edema forming 
states. Before citing some of the work accomplished in this area, a 
consideration of the physiologic consequences of intrarenal flow 
redistribution and how it relates to third factor would be appropriate. 
From basic physiology one may recall that four renal medullary factors 
regulate renal concent rating-~and sodium reabsorbinq--abi1ity: (1) the 
rate of sodium pumping and countercurrent multiplication by the loops of 
Henle, (2) the rate of washout and dilution of medullary solutes by 
medullary blood flow, (3) the rate of washout and dilution of medullary 
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solutes by urine, and (A) the permeability of collecting duct eipthelium 
[20]. Compared with countercurrent exchange in the cortex and outer 
medulla, that occurring in the inner medulla via long parallel vasa recta 
is exceedingly more efficient. Moreover, in the outer medulla and cortex, 
there is greater washout and dilution of sodium and urea, leading to 
decreased concentrating ability and sodium reabsorption. Augmentation of 
medullary blood flow presumably lowers sodium concentration in the medulla, 
thus enhancina reabsorption by the loops of Henle (2° to smaller back 
diffusion of sodium). In addition, arteriolar vasoconstriction Sn the 
outer cortex decreases hydrosatic pressure in the peritubular capillaries, 
thereby encouraging proximal reabsorption of sodium and water. Finally, 
salt reabsorption is enhanced at the medullary level by virtue of the 
longer loops of Henle located there. Hence, if blood is shunted from 
the cortex to the medu11a--as may be the result of cortical vasoconstrictive 
sympathetically-mediated activity--sodiurn reabsorption would be promoted. 
Poneranz [20] studied the effect of renal nerve activation on intra- 
renal capillary blood flow in conscious and anesthetized dogs. This was 
accomplished by eliciting a chronic or acute carotid sinus reflex and by 
chronically or acutely stimulating the splanchnic nerve. Techniques employed 
here included 85 Kr radioangiography, 85 Kr clearance studies monitored 
by x-ray scintillation and preparation of silicone rubber casts of the 
microvasculature. The conclusions drav/n from his experiments were that 
mild renal nerve stimu 1 ation--which may not alter overall RFB--does 
result in diminished perfusion of the outer cortical peritubular capillaries. 
Concurrently, perfusion appears to be increased in the outer medulla. 
Furthermore, such redistribution in chronically stimulated animals could 
be reversed with infusions of phenoxybenzamine into the renal artery or 
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blockage of nerve conduction with xylocane. 
The clinical implications of such an experiment are evident. As a 
result of sodium depletion or hemorrhage, intravascular volume contracts 
and the blood pressure falls. Activation of haroreceptor and central 
vasomotor autonomic reflexes would then lead to renal nerve stimulation with 
concomitant redistribution of blood flow in the kidneys (cortex to medulla). 
Sodium and water is reabsorbed with qreater efficiency, and the blood 
pressure is ultimately reestablished. Carriers [21] provided further 
evidence in support of this reasoning by investigating the intrarenal 
distribution of blood flow in dogs during hemorrhagic hypotension. 
Employing techniques similar to those mentioned above [20], he showed 
that such hypovolemia led to progressive diminution of cortical flow; 
while flow rate within the juxtamedu11 ary compartment was well maintained. 
Since the flow rate was normal at half the blood pressure In this latter 
region, vascular resistence here must have been reduced by 50 per cent. 
Conversely, vascular resistance must have been elevated 100 per cent in 
the outer cortex. involvement of adrenergic activity was suggested by 
this worker, in view of similar patterns of redistribution resulting from 
renal nerve stimulation, or renal arterial infusions of catecholamines. 
During states of sodium deprivation In rats [22] and man [23] 
preferential cortical to medullary shunting of RBF has been demonstrated. 
The consequences of this with respect to sodium metabolism are of major 
importance, particularly when the animal needs to retain sodium--or does 
so ob1igatori1y--whether under conditions of a low sodium diet or under 
the stimulus of an edema forming state .. As stressed before, the longer 
intramedullary nephrons are more efficient at sodium reabsorption. 
Moreover, a decreased cortical single nephron glomerular filtration rate 
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(SNGFR) (as was observed in rats during low sodium diets [22]) should 
allow for more thorouqh sodium reabsorption in these shorter nephrons. 
Indeed, one need not even postulate a decreased SNGFR within the cortex; 
since mere reduction of RBF (via sympathetically mediated arteriolar 
vasoconstriction with maintenance of GFR will increase the filtration 
fraction. Peritubular hydrostatic pressure falls as a result, oncotic 
pressure rises, and sodium reabsorption is facilitated via these third 
factor forces. 
Perhaps the most excitinq investigations concerning the interaction 
of the sympathetic nervous system and renal mechanisms of sodium metabolism 
have focused on the relationship between adrenergic activity and release 
of renin by the kidney. Anatomic studies have demonstrated fluorescent 
varicosities, having the same morphologic characteristics as norepinephrine" 
containing nerve terminals, in the walls of intrarenal arterioles [24], 
Moreover, this innervation has been found to extend into the parts of 
these arteriolar walls containing granulated juxtaglomerular cel 1s--the 
storage sites of renin. This work, together with that of Ljungqvist [9], 
Barajas [25,26] and others, suggests, but does not prove, a direct role 
of adrenergic innervation on release of renin by the juxtaglomerular cells. 
Somewhat more direct evidence in favor of this argument has derived 
from several more physiologic-biochemical experiments. For example, plasma 
renin activity (PRA) is elevated in anesthesized dogs given intravenous 
epinephrine or norepinephrine, or whose renal nerves have been stimulated 
(with maintenance of constant renal arterial pressure) [27]. Toqulni et 
al. [28] described a decline in the renin content of rat kidneys following 
denervation. 
In attempt to establish the existence of autonomic influence on renin 
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release, Bunag, Page, and McCubbin conducted a provocative experiment 
on anesthetized adult mongrel dogs [29]. These animals were hemorrhaged 
to a degree sufficient to engender diffuse vasomotor discharge (as 
evidenced by compensatory tachycardia etc.). This resulted in an increase 
in PRA, even though renal perfusion pressure was artificially held 
constant. Since a rough correlation existed between the compensatory 
tachycardia and renin release, the effect was felt to be sympathetic. 
Moreover, adrenergic discharge elicited by carotid occlusion also produced 
an elevated PRA (again with constant renal perfusion pressure). Renin 
release was prevented with ganglionic blockade (TF.AC) or by local anesthesia 
of the renal nerves. In contrast, infusions of norepinephrine, tyramine, 
or DMPP (dimethy!pheny1piperaziniurn, a ganglionic stimulator) evoked elevated 
PRA. Finally, all these results were amplified by placina the animals, 
beforehand, on a low salt diet. 
Moail measured PRA in normotensive and renal hypertensive dogs 
Sn the presence and absence of renal innervation, under a variety of 
stimuli designed to affect renin-angiotensin activity [303 * His conclusion 
was than intact renal sympathetic innervation is necessary for the renin- 
angiotensin system to respond normally to changes in sodium balance. 
However, it should be noted that others have reported elevated renin-angio¬ 
tensin levels in denervated doas during and following hemorrhagic shock [313- 
Moqil offers two possible modalities by which the sympathetic nervous 
system might affect the release of renin: (1) by altering afferent arteriolar 
vasoconstriction proximal to (or at the site of) the juxtaglomerular 
baroreceptoi—-thus changing local hemodynamics and subsequent release of 
renin, or (2) by increasing the sensitivity of juxtaglomerular cells to 
various stimuli which affect the release of renin. 

From a more clinical standpoint, measurements of PRA have been made 
in man, following intravenous infusion of catecholamines and in rats, in 
response to cold stimulation of the sympathetic nervous system [32]. 
Despite concurrent elevations of blood pressure, PRA and aldosterone were 
observed to be increased. Similarly, sodium depletion and upright posture 
resulted in rising PRA and urinary catecholamines and aldosterone. How¬ 
ever, patients with severe autonomic dysfunction, who were salt depleted 
or in upright posture, did not experience an elevation of any of these 
values--notwithstanding a substantial fall in BP. But when their ortho¬ 
static hypotension was prevented by iv. catecholamines, there was noted 
to be a normal rise in PRA and aldosterone in response to the previously 
mentioned challenges. Further studies such as this support the contention 
that the sympathetic nervous system does play a direct intrarenal role in 
the mediation of the renin-angiotensin system [33,3*0- 
Such observations and arguments, as presented above, permit a more 
physiologic approach toward comprehending the pathophysiology of various 
sa1t-retainIng or edematous states. For example, greater than normal 
amounts of catecholamines have been found in the urine of nephrotic patients, 
suggesting increased sympathetic activity probably secondary to a 
contracted circulating blood volume [35]. Concomitantly, renin and aldo¬ 
sterone are elevated. In congestive heart failure, catecholamine levels 
are characteristically increased in both urine [3&] and plasma [37]; 
several observers have described areater than average arterial and venous 
tone [3^]. As in nephrosis, this apparent heightened sympathetic activity 
probably reflects a relative (or absolute) hypovolemia. Its major intra¬ 
renal effect is probably a vasoconstrictive one altering such third factor 
forces as filtration fraction, redistribution of blood flow, etc., so as 
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to facilitate sodium reabsorption. Finally, renal vascular resistance is 
increased along with depressed P.BF in hepatic cirrhosis, despite overall 
expansion of ext race 11u1ar volume and cardiac output [39]. There is 
evidence to ascribe these changes to decreased arterial filling (via 
adrenergic activity), leading to higher FF and redistribution of blood 
(cortex to medulla). Sodium reabsorption is enhanced. 
In summary, there appears to be one abnormality common to all of the 
above mentioned edema-forming states: an inadequacy of arterial fi11ing— 
whether a consequence of contracted blood volume, decreased cardiac output 
or supernormal run-off of arterial blood to venous circulation via fistula 
Such a situation leads to increased adrenergic activity with the following 
sequelae: (!) immediate defense of the circulation by augmentation of 
cardiac output and peripheral arteriolar vasoconstriction, (2) secretion 
of renin and aldosterone, in part due to sympathetic mediation, (3) renal 
vasoconstriction with intrarenal flow redistribution, resulting in 
depressed RBF and concomitant physical hemodynamic factors contributing 
to increased sodium reabsorption. 
An experimental model of low-output congestive heart failure has been 
constructed by constriction of the thoracic inferior vena cava (T1VC) in 
dogs. Such a maneuver effects a decline in the circulating blood volume 
with two major consenuences. First;the arterial pressure is defended by 
reflex baroreceptor stimuli to the vasomotor center. Resultant efferent 
adrenergic stimuli auqment cardiac contractility and peripheral vaso¬ 
constriction. Second, an attempt to restore intravascular volume to an 
effective level is made by increasing sodium reabsorption via an interplay 
between the determinants of GFR, aldosterone secretion, and third factor. 
Kilcoyne et al. studied the effect of TIVC occlusion on intrarenal 
-13- 

1 3 3 
blood flow and sodium hemostasis in mongrel dogs [*t0], -^Xe washout 
minotored by Y- ray scintillation v/as employed in this investigation. 
Paralleling the results of others [20,21,23], his data indicated that 
acute TIVC occlusion produces a marked sodium retention and significant 
redistribution of renal blood flow. This he characterized as diminished 
perfusion in the superficial cortex with its short nephron population 
and rich sympathetic innervation. Moreover, while whole kidney GFR 
remained constant, urinary sodium excretion declined. As a corollary to 
these findings, it was observed that unilateral infusion of norepinephrine 
produced similar vasomotor changes and renal sodium retention. In 
addition, he found that renal denervation or infusion of0^-adrenergic 
blocking agents reduced, but did not prevent, TIVC occ1 usion-induced 
vascular redistribution [41]. The implied role of the sympathetic nervous 
system here is obvious. And the significance of these results relative 
to the pathogenesis of edema should be stressed; since similar redistribution 
of blood flow and reduced sodium excretion has been noted in dons with 
experimental heart failure [42], pulmonary artery constriction, or tricuspid 
avulsion [39]. 
Summary: This review has emphasized that sodium metabolism is 
modulated not only by variations in overall GFR and aldosterone-mediated 
tubular reabsorption, but also by an amalgamation of third factor influences. 
These include changes in peritubular hydrostatic or oncotic pressure, a 
postulated natriuretic hormone, and intrarenal distribution of blood flow 
(or glomerular filtrate). Much evidence--anatomic, physiologic, and 
pharmacologic--has been adduced to establish a significant role for the 
sympathetic nervous system in these third factor forces. Moreover, an 
important interplay between renal adrenergic activity and renin secretion 
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has been suggested. Finally, these physiologic observations have been 
placed into a clinical perspective by definino the part they may play in 
the pathogenesis of edema. 
FINE STRUCTURE OF THE SYMPATHETIC NERVOUS SYSTEM 
in contrast to the distinct neuromuscular junction of motor neurons, 
sympathetic nerves terminate in an extensive ground plexus. Each fiber 
of this branchina network is in close proximity to several effector cells 
and is characterized as having many beaded dilations, or varicosities, 
along its length. V/ ? thin these varicosities are mitochondria and membrane 
bound vesicles, much akin to those described in the adrenal medulla [433 . 
The intraneuronal distribution of the sympathetic neurotransmitter, 
norepinephrine (NE) , is uneven, with small concentrations in the soma and 
axon, but large concentrations in the varicosities. Several workers have 
localized the NE within varicosities to the adrenergic vesicles [44,45]; 
although a small ext ravesicu1ar pool does exist. There is virtually no 
extraneuronal ME in adrenergica11y innervated tissue [46]. 
Three types of synaptic vesicles have been described in axon varicosities 
(1) small agranular vesicles (30Q-600A diameter) similar to those seen in 
most cholergic nerve endings, (2) small granular vesicles (diameter 300-600A) 
with dense cores (diameter 150-250A), and (3) large granular vesicles 
diameter 600-I500A) with a central core (A00-700A). That NE is predominantly 
localized in small granular vesicles (hereafter often referred to as 
"granules"), has been concluded from electron microscopic, histochemica1, 
and microfluorimetric investigations [46]. 
Through such techniques as differential and density gradient 
centrifugation, the biochemical characteristics and momhogenes i s of the 
granules has been partially elucidated. They are membrane bound, 
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assembled in the cell body, and transported along the axon to the nerve 
ending. Here, their life span has been estimated to be 5-10 weeks [47]. 
In addition to storing ME, vesicles contain lipid, phospholipid, proteins, 
RNA, and ATP. The protein components, of which dopamineo$-hydroxylase is 
one, are referred to as chromogranins. Aside from the biosynthetic role 
of dopamine^-hydroxy 1 ase, the role of chromogranins remains undefined; 
although much speculation focuses on their participation--along with ATP-- 
in the intravesicular binding of ME. 
The adrenergic nerve terminals contain all the enzymes, cofactors, 
and precursors necessary for ME synthesis and storage. Tyrosine hydroxylase, 
the first enzyme in the biosynthetic pathway and apparently the rate- 
limiting one [48], is confined to the soluble fraction of the cell. Prior 
to hydroxylatIng l-tyrosine to L-Dopa the enzyme must first be hydrogenated 
by a reduced pteridine cofactor. A dihydropterIdine reductase is present 
in the adrenal medulla, and presumably, in sympathetic neurons. Also 
located in the soluble cell fraction is aromatic L-amino acid decarboxy¬ 
lase. >t is a pyridoxal-requiring enzyme and catalyzes the conversion 
of L-Dopa to dopamine (DA). 
Unlike the previously mentioned enzymes, dopamine^-hydroxy 1 ase is 
within the storage granules. Indeed, DA must be taken up by the 
oranules prior to its ^-hydroxyl at Ion. There is some evidence available 
to suggest that most dopamine-^-hydroxy 1ase is bound to the sympathetic 
neuron vesicular membrane [46]. 
The requlatory mechanisms of catecholamine biosynthesis are not 
unlike those described for other anabolic pathways. Rate of ME synthesis 
is a function of the availability of cofactors, enzyme substrates, and 
the amounts and activities of these enzymes. ME contributes to the control 
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of its biosynthesis via feedback inhibition of trysoine hydroxylase, 
probably by competition with the pteridine cofactor for the oxidized 
form of the enzyme. It has been postulated that the small ext ravesicu1ar 
pool of free ME is involved in this competitive feedback inhibition. At 
a higher level of organization, changes in sympathetic activity are 
reflected by concurrent alterations in catecholamine turnover rates, though 
tissue levels remain constant. In fact, prolonged sympathetic nerve 
stimulation results in enzyme induction of tyrosine hydroxylase [^7,^93- 
Finally, there is biosynthetic regulation at the interface of various 
intracellular compartments, i.e. granular uptake of dopamine may be rate- 
limiting under certain circumstances [473 • 
The uptake and release of ME by in vitro granular preparations has 
3 
been investigated by several workers. Within one minute after Iv. H-NE 
into rabbits, Titus noted that 25 per cent labeled ME was recoverable in 
particle-bound form from homogenates of the heart [50]. Similar results 
are obtained in the rat [51]. The uptake process appears to be temperature 
dependent, with lowest activity at [52], Although even at O^C, splenic 
nerve vesicles are permeable to ME, permitting exchange of ^H-NE with 
endogenous ME in vesicles [53]. Indeed, Potter [52] describes the 
immediate adsorption of 17 times the solution concentration (10-7M) of ME 
to splenic nerve granules at A°C. Owing to the heterogeneity of granular 
preparations, there is great variation in the Inhibition of vesicular ME 
uptake by such agents as reserpine or EDTA 3 »Sl\, 52 ]. Finally, It 
appears that ME must be stored in the granules prior to release [47]~"a 
process much like that occurring at the neuromuscular junction. 
Many studies have supported the generally accepted notion that 
minature endplate potentials and synaptic transmission at the skeletal 
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neuromuscular junction are mediated by complete presynaptic exocytosis of 
acetylcholine-containing vesicles. Evidence for a similar "quanta!" 
release of NE-containinq vesicles durinq synaptic transmission in adrenerqic 
neurons, is not nearly as extensive as that obtained for the skeletal 
neuromuscular junction. However, all electrophysiologic and biochemical 
data gathered so far can be explained in terms of this excitation-secretion 
coupling model [46,52,55~59]- Strong parallels can be drawn to the 
secretion of catecholamines by the adrenal medulla. The mechanism by 
which the vesicular contents are discharged into the extracellular space, 
leaving the membrane behind in the cvtoplasm, is not clearly understood. 
Evidence points to an interaction of the sympathetic nervous stimulus, 
calcium influx, and the resultant granular membrane effect producing 
vesicular exocytosis [4?3 - 
Having been released into the extracellular space, the effect of ME 
is short-lived; as it is rapidly taken up into the sympathetic nerve. 
Extracellular ME is also catabolized to O-methylated derivatives; although 
this is quantitatively of less significance than re-uptake. Briefly, 
the re-uptake mechanism is located in the axonal membrane, and quite 
distinct from the similar process at the granular level. Drugs such as 
cocaine, sympathomimetic amines, receptor antagonists, neuron blocking 
agents, phenothiazines and tricyclic antidepressants block re-uptake. 
TURNOVER OF CATECHOLAMINE 
Nearly all NE outside the adrenal medulla and CMS is located in 
peripheral nerve endings. Hence, the ME content of a particular tissue 
is a reflection of its sympathetic innervation. As a corollary to this, 
the absolute level of cathecholamine for a specific tissue remains contsant 
and is generally not subject to change under norma 1 circumstances. However, 
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there is variation between tissue types. This relation holds true, 
despite variations in the level of sympathetic activity. Since NE is 
released from granules in response to nerve stimuli (or following the 
administration of indirect-actinq sympathomimetic agents) a dynamic steady 
state must exist where catecholamine biosynthesis and utilization are 
in balance. Therefore, sympathetic activity should be assessed, not by 
measurement of steady state tissue levels of NE, but by measuring ME 
turnover using the techniques of steady state kinetics. 
Of the various modalities available to measure turnover, one of the 
more popular, and the one used in this thesis, involves the use of tracer 
amounts of tritiated ME (^H-NE). A tracer dose of ^H-NE, intravenously 
administered, is taken up by the axonal membrane [60,61] and equilibrated 
with endogenous ME stores [62). It thus serves as a valid marker of NE 
release [63]. As noted before, alterations in adrenergic nerve activity 
effect concurrent changes in ME release and biosynthesis. Thus, following 
the introduction of tracer ^H-NE, the intracellular concentration of label 
(or its specific activity) will decline as a function of time and adrenergic 
activity [6A]. This rate of decline may be used to calculate the turnover 
rate of ME, and concomitantly, gauge the level of sympathetic activity. 
Several authors have provided substantial theoretical and experimental 
support for this approach, and have utilized it in measuring levels of 
adrenergic activity in various organs under different conditions of stress. 
For example, landsberg et al. demonstrated in Spraque-Dawley rats that 
increased "de novo" biosynthesis of catecholamines occurs coincidentally 
with augmented turnover [65]. Another study revealed increased NE turnover 
in the heart of male albino rats injected with ^H-NE three hours before 
such stressful stimuli as cold, electric shock and immobilization [66], 
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Finally, Taubin et al. determined fractional turnover, half-life and 
■? 
turnover rate of H-NE at various levels in the rat gastrointestina I 
tract [67]. They found the highest level of ME turnover to be in the 
duodenum and the colon. These areas also demonstrated the largest 
concentration of ME, as established by histochemicaI fluorescent studies. 
The validity of these turnover experiments derives from a few very 
fundamental kinetic principals. In the paragraph to follow, a mathematical 
foundation for the kinetic analysis used in this thesis is presented. 
First, it should be recalled that the tracer turnover technique 
takes advantage of the steady state kinetic principle that rates of 
synthesis and loss of catecholamines are equal. Moreover, the removal 
of ME is proportional to its concentration. Let K = rate of decline (or 
synthesis) of ME, [NE]t= normal tissue amine concentration at time = t, 
and k = rate constant of ME efflux. Then K = k[NE31• Under steady state 
conditions, the decline in catecholamine concentration is expressed by 
the following relation: -d liiLl = k[NE1 (1). Inteqratinq (1) from time 
0 to time = t, one 
Convertlnq to log |q* 
where [ME]0 = initial level; [NE]t - level of amine at time = t. A plot 
of log [ fJ E ] t vs. time yields a straight line with slope equal to -0.43** k, 
or the rate constant of ME efflux. Therefore k[ME]t " rate of ME efflux = 
rate of ME synthesis in the steady state. If K = k[NE]t, then k is 
the fraction of total NE that is formed or lost per unit time, or 
fractional turnover. The reciprocal of k or k~^ or [NElf/K is the time 
required for the biosynthesis of an amount of NE equal to that initially 
stored in the tissue, or the turnover time [68]. 
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OBJECTIVES OF THE THESIS 
As emphasized previously, a more realistic measure of sympathetic 
activity is reflected In the turnover rate of catecholamines, rather than 
by determinations of absolute tissue levels. Application of this 
principle, therefore, permits a more direct correlation of adrenergic 
activity and the various sympathetically mediated physiologic phenomena. 
Of particular Interest to me, is the role played by the sympathetic nervous 
system in the metabolism of sodium by the kidney. Hence, my primary 
objective in pursuing this research was to demonstrate that renal 
catecholamine turnover did exist, and could be measured. It is hoped that 
further research will apply the methods developed and the results obtained 
here In such physiologic studies as the impact of sodium deprivation on 
renal catecholamine turnover. All such efforts should advance our 
understanding of the mechanisms behind non-aldosterone mediated tubular 
reabsorption of sodium. 
MATERIALS AMD METHODS 
3 
The quantity of intravenously administered H-NE taken up by a tissue 
under normal conditions is a function of three major parameters: (1) the 
amount of sympathetic innervation characteristic for such a tissue [69], 
(2) the percentage of cardiac output delivered to the tissue, and (3) the 
level of adrenergic activity, or sympathetic tone, extant at the time of 
injection. Depending upon the organ under investigation, however, there 
may be modifications of, and additions to, the above considerations. For 
example, uptake by the brain is complicated by the presence of a blood 
brain barrier. The kidney also presents special difficulties In measuring 
catecholamine uptake and subsequent turnover. Following Iv. Injection of 
3h-ne, unincorporated JH-NE and Its labeled catabolites collect in the 
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urine. These are a source of potential contamination when the kidneys are 
prepared for measuring H-NE. Attempts were made to overcome this problem 
in the experiments to follow. 
Female Sprague-Dawley rats (140-215 grams), were purchased from the 
Charles River Company, V/i Imingham, Massachusetts. H-L-ME was obtained 
from the Mew England Nuclear Corporation and purified prior to use by 
adsorption onto an alumina column at pH - 8.6, This was eluted from the 
resin with 0.2N acetic acid and preserved in a refrigerator with small 
amounts of ascorbic acid. 
3 
Tracer H-NE was introduced into the rats by tail vein injection. 
At appropriate times, animals were sacrificed by a blow to the base of the 
skull and hearts and kidneys extirpated. These were prepared by either 
immediate homogenization in iced 0.AN HCIO^ (to preserve and release all 
the catecholamines), or by differential centrifugation in 0.25M iced 
sucrose (to be described) to obtain a vesicular fraction. The latter 
was then homogenized in iced 0.4N HC!0/t. After acidification with per¬ 
chlorate, precipitated protein was removed by centrifugation. ME was 
subsequently obtained from the supernatant by adsorption on alumina, 
previously equilibrated with sodium acetate pH 8.6 [70,71]. Radioactivity 
of 3|!-NE was determined by counting aliquots of alumina eluate for ^H-NE 
by liquid scintillation spectometry on a Packard Tri-Carb scintillation 
counter (18 per cent efficiency). Attempts to determine endogenous NE were 
made by the trihydroxyindole method of Von Euler and Lishajake [72], 
(Aminco Bowman Spectrophoto-f1uorometer). In turnover experiments, activity 
of the sympathetic nervous system with respect to time was measured in 
3 
terms of muc H-NE/gram tissue, and corrected for varying recovery from 
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the alumina column.* 
Perfusion of kidneys In situ: 
In an effort to remove all unincorporated catecholamine and labeled 
cataholites from tubular lumens prior to extirpation of the organ for 
analysis, an attempt was made to perfuse the kidneys with saline. The 
aorta was cannulated with a 21-qauge Butterfly needle, and ligatures placed 
above the take-off of renal arteries from the aorta and below the site 
of cannulation. Iced saline was then infused with a syringe. Samples of 
urine were taken from the bladder and used for scintillation counting, 
endogenous ME determinations, and measurement of creatinine. 
Preparation of vesicles from sympathetic nerve endings in the kidney (Fig. 1): 
Preparation of this subcellular fraction by differential centrifugation 
has been achieved in several laboratories [52,73]- In the experiments to 
follow, the extirpated organs were immediately chilled on crushed ice and 
then homogenized in 0.25M sucrose, 4°C, (At all times, close attention was 
paid toward keeping the preparation as near as 4°C as possible.) The homogenate 
was then centrifuged 10,000 X g for 15 minutes in a Sorval! R—11. Super¬ 
natant, Fr I, containing vesicles, was subjected to centrifugation in a 
Spinco Model L ultracentrifuge at speeds of 100,000 X g for 1 hour, b°C. 
Both pellet and supernatant obtained after this step were saved and treated 
*As will be described later, attempts to measure enodgenous ME in the kidney 
were unsuccessful. Hence I was obliged to quantify adrenergic activity in 
terms of concentration of ^H-NE, that is, muc ^H-NE/gram tissue. The validity 
of this is based upon two assumptions. (I) Endogenous ME content varies 
among tissues within the animal. (2) Relative to each tissue, ME content/ 
gram is approximately the same among animals of the species. Clearly, it 
would be more desirable to have measured endogenous ME so that specific 
activity, instead of concentration, could be used. 
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Homogenate (0*25M sucrose) 
Precipitate (discard) 
*- 
Supernatant (Fraction III) 
1 
Centrifuge 10,000 x g for 15 minutes 
l 
Supernatant (Fraction I) 
Centrifuge 
vi 100,000 x g for 1 hr 











(Fraction V: (discard) 
vesicular fraction) 




as fol lews. 
ME In the supernatant (Fr Ml) was preserved by acidifying the 
preparation with b.O M HCIO^. Final volume was 13.0cc and concentration/ 
equal to O.AN HCIO^. Proteinaceous precipitate was removed by centrifugation 
at low speed. The pellet (Fr II), containing vesicles (granules) and other 
microsomal components, was washed three times with 0.25M sucrose (4°C) and 
then resuspended in O.^M HCIO^ (to free ^H-NE). This preparation was re¬ 
homogenized, and centrifuged at low speed to obtain the supernatant. Fraction V 
(final volume = lO.Occ). Fractions IV and V v/ere ultimately applied to an 
•3 
alumina column to allow separation of H-ME from its labeled metabolites. 
Vesicular preparation from^ rat heart: 
The procedure was the same as that for the kidney, v/ith the exception 
that interest was directed primarily toward the pellet (Fraction V). 
Determination of nonspecific uptake or adsorption of -ME to granules from 
heart and k?dney: 
Hearts and kidneys from animals not administered a tracer dose of 
-M-l-NE were homogenized in 0.25M sucrose to which 50 u 1 of 280 yic/cc DL-'H-NE 
had first been added. Supernatant (Fr IV) and granular (Fr V) preparations 
were obtained as outlined above and concentration of ^H-NE determined after 
purification v/ith alumina. Per cent nonspecific uptake was obtained using 
the following formula: 
[3h-NE] Fr V 
Per cent = T^NE] v I [3H-NE] | V 
B1ockade. of_ nonspecific uptake or adsorption of Ml “NE : 
In a series of experiments, heart and kidneys were homogenized at *t°C 
3 
in 0.25M sucrose with H-ME (0.65-0.87 ^jc/cc) and various agents knov/n to 
inhibit uptake of ME by vesicles. Granular preparations v/ere then obtained 
3 
by differential centrifugation and H-NE measured. Though several rats were 
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used, each served as its own control control since one kidney and 
one-half a heart were incubated with H-DL-ME in the absence of inhibitors 
while the other kidney and one-half heart were subjected to inhibition. 
Based on the per cent nonspecific uptake by the control, a per cent 
inhibition of uptake by the inhibitor could he ascertained. The agents 
and their concentrations were as follows: 
(1) Reserpine (10-^M) + EDTA (3 x lO-^M) 
(2) Monisotopic DL-ME (1.47 x 10-6M) + EDTA ( 3 x 10-3M) 
(3) Mon isotopic DL-ME (2.9 x 10-5M), (1.2 x 10-\l), (1.2 x 10-3M) 
•j 
Per cent uptake was calculated from the ratio, [ H-NEjy * w*1ere 
V and IV refer to 3H-NE in pellet and supernatant, respectively. 
Turnov ejr .0 f 3H-ME in rat he art a nd kidneys : 
Twenty Sprague-Dawley female rats (137-169 grams) were divided into 
3 administered 
groups of five, and H-L-NE/(400 |jc/kg) by tail vein injection. At 
intervals of one-half, 3> 7, and 12 hours respective groups were 
sacrificed by a blow to the base of the skull. Organs were rapidly 
removed, blotted dry, and weighed. (Extreme care was taken to ensure 
that kidneys were free of adrenal gland tissue.) Each animal was treated 
in the following manner: (1) One kidney was immediately homogenized in 
0.4N HCIOjj (4°C) (’'perchlorate kidney"), while a granular preparation was 
obtained from the other. (2) The hearts were divided in half, with one 
portion set aside for immediate homogenization in 0.4N HCIO^ ("perchlorate 
heart"); and the other used to prepare vesicles. Aliquots were obtained 
prior to, and following passage over the alumina column for counting via 
scintillation spectrometry. 
Effect of gang 1 J_o n i c b 1 oc k a g o n catech oj amine t urn over: 
Twelve female Sprague-Dawley rats v/ere injected intravenously with 
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^H-L-NE at a dose of 420 ^ug/kg. At 5 minutes and 3 hours after administration 
of 3h-NE, half the animals were given ch1 orisondamine hydrochloride 
(15 mq/kq) intraperitoneally. The remainina six served as controls and 
were injected with saline, ip, at the above times. Six hours post H-ME 
injection, the animals were sacrificed and kidneys and hearts were removed, 
A vesicular preparation (Fr V, IV) was obtained from the kidneys. However, 
the hearts were merely blotted dry and homogenized in 0.4N HCIO^* 
Concent rat ion of ^H~ME (m^ic/g) was determined before and after application 
to alumina. 
Kinetic analysis: 
In the introduction it was pointed out that under steady state 
conditions, the removal and formation of catecholamine are in balance. 
Moreover, the disappearance of catecholamine is proportional to Sts 
concentration at any time. That is, -d [ME 3^/d t = k [ N Ewhere k is the 
rate constant of NE efflux. This relationship is an exponential one, 
describes the curve Y = abx, and involves a constant ratio of change--a 
constant ratio of change in the amount of change. If b is greater than 1, 
the trend is upward; and the amount of change is undergoing a constant 
percentage increase. Conversely, St b is less than 1, there Is described 
a downward trend, with the amount of change showing a constant percentage 
of decrease. No change results ?f b = 1. 
This exponential relation may be made linear by converting to 
logarithms: log Y = log a + x log b. Here the slope is represented by 
log b and y-intereept, by log a. Thus, to calculate the percentage 
increase or decrease of an exponential function, one need merely determine 
the slope, loq b; find the anti log b; and then subtract this from 1 (or 




In the turnover experiment, log y is concentration */H-N£ (rnyc/g) 
and x represents time. By the method of least squares, log y was plotted 
vs time and a line of regression obtained. This was plotted on semi log 
3 
paper with the standard error about the mean concentration of H-NE for 
each time interval. The slope (log b) is easily determined and used to 
calculate the rate constant of decline (per cent of pool declining per 
hour), k, or fractional turnover. Turnover time is obtained by finding 
the reciprocal of k and multiplying by 100. Finally, half-life of NE is 
calculated by dividing 0.693 by k, and then multiplying by 100. 
Statistical analyses were used to determine the coefficient of 
3 
correlation between decline in concentration of H-NE and time for each 
preparation. Moreover, the standard t-test was utilized to establish the 
effect of chlorisondamine on turnover of catecholamine. 
RESULTS 
I. Measurement of endogenous NE in kidneys and heart, using whole organ 
homogenates 
Unfortunately, the fluorimetric assay of renal endogenous ME (after 
passage of homogenates over alumina) was repeatedly frustrated by high 
blank readings. Apparently a nonproteinaceous material resides within 
the kidney, is eluted from alumina along with ME, and reacts in the 
trihydroxyindole procedure to obscure the fluorescence of catecholamine. 
It is of note that this substance is absent in the urine. See Figure 2 
and Tables 1 and 2. 
An attempt to side-step this difficulty was made by applying the 
alumina column eluate to a Dowex cation-exchange resin. Blank readings 
were much diminished; however, there was little difference between blanks 
and sample readings, making calculations somewhat unreliable. Table 3* 
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This is most likely attributable to the large dilution factor encountered 
using two exchange columns. 
Vigorous effort was devoted toward refining this two-column procedure; 
but fluorescence readings continued to be so low that consistent 
determinations could not be made. Some of our results indicated endogenous 
renal ME concentration of from 50-707 ng/g tissue. Hence, it was felt 
that although it appeared possible to make determination of endogenous 
NE by the two column method, the results were not reliable enough to 
justify use of this method in the experiments to follow. Instead, the 
decision was made to measure sympathetic activity in terms of m|jc 'H-HE/ 
gram tissue, rather than per ng ME--a less meaningful quantity, but not 
so much so as to jeopardize the validity of our results. 
JJ . Perfusion of rat kidneys in situ 
Several attempts were made to perfuse the kidneys in situ with saline 
in order to remove unincorporated ^H-NE (and labeled catabolltes from 
tubular lumens. Clearly, it is not desirable to have these "contaminants" 
contributing to the determination of H-ME taken up by the sympathetic 
nerve endings. 
The perfusion attempts, however, were exceedingly time consuming and 
did not effect a free f1ow of urine. Rather than persist In this endeavor, 
the decision was made at this juncture to attempt purification of the 
■3 
vesicles. For it is in the vesicles that incorporated JH-NE would be 
stored, prior to subsequent release. There is, therefore, theoretical 
justification for pursuing this line of attack. 
III. Determination of endogenous HE of vesicles and their nonspecific 
uptake of ^H-NE 




Formula for calculation of endogenous norepinephrine: 
a. RIS (fluorescent reading for internal standard) = amount of fluorescence 
for 100 ng norepinephrine added + amount of fluorescence due to NE in 
0*5cc eluate (RIS = fluorescence of lOOng NE + x) 
b. x = fluorescence of x’ ng NE in eluafe 
e« b = fluorescence of blank 
d. CF - correction factor for # recovery of NE from column, aliquots removed 
for various measurements etc. 
x ® ng NE~ - x - b 
100 ng NE (RIS - b) X' x'T b]P 
x® ng NE = (100 ng NE) (CF) 
(RIg - x) 
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Rat # Weight of_ 
Rat(g) 
Combined wt» 
of kidneys g 
Vol. urine from 
bladder cc * 
Dos© 3H-NE 
ug/kg iv. 
1 260 2.31 
iH 
233 
2 262 2.80 0.2 233 
3 231 2.54 0.2 h 
Qo2 ; 
100 
4 231 1.67 100 
5 200 1.86 0.2 \ 100 
* 0.2 ee urine diluted to 5*0ec with 0.4N HCIO^ 
Table 1. Determination of endogenous NE in alumina eluate from rat kidneys 
and urine, in a typical experiment — experimental set-up for 
values obtained in Table 2. 




Rat# 1 94 40 37 120 99.5 
# 2 108" 51 54 100 - 89.0 
# 3 92 38 39 116 - 33.2 
# 4 90 41 36 123 - 51.4 
# 5 86 40 39 102 - 93.6 
Std 1* 138 55 53 10 552 - 
2 145 67 64 8 ?60 « 
140 65 65 6 819 - 
U 2f 73 10 10 7 66 - 
3 84 9 8 9 * - 
4 86 22 17 5 364 
5 90 14 8 10 21 
* Std 1,2,3 : 1000 ng DL NE applied to three alumina columns so that $ recovery 
of NE off columns could be calculated. 
4 U 2,3*4,5 : refers t© values obtained from urine aliquots of rats 2,3*4,5 
Table 2. Values obtained in fluorescence assay for endogenous NE from kidneys 
and urine of rats described in Table 1. Renal concentration of 3h«NE 
determined by scintillation spectrometry also presented® 
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Sample X X b ng NE ng NE/g tissue 
Rat # 1 95 14 12 6 1633 70? 
2 99 12 12 14 
3 88 3 5 15 - 
4 90 13 10 13 • 
5 100 11 10 8 438 236 
Std # 1 100 13 10 14 » 
2 100 14 15 11 113 «» 
3 105 12 17 7 230 - 
Table 3* Fluorescence assay for endogenous NE after passage of alumina column 
eluate (Table 2) o¥er a Dowex cation exchange resin. 
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not been described. One such property of some importance in future 
turnover experiments is the extent to which a granular preparation 
nonspeclfically adsorbs 'H-NE. An approach to this problem is outlined 
in Methods, and the results presented in Table h. 
From these data St became clear that nonspecific uptake, or 
adsorption, of H-NE by the vesicles did occur. These findings were not 
surprising, as they are in accordance with those of Potter and Gil Us. 
An effort was also made to measure endogenous NE in vesicular 
preparations after elution from alumina. Both kidneys from a rat v/ere 
pooled and granules prepared according to Methods. Results of the 
fluorimetric assay, Table 5, demonstrate ME levels so low (or blanks so 
high) as to preclude reliable calculations of endogenous NE, 
I V. B1ockage of nonspecif j c uptake or adsorption of ^H-NE by the vesic1es 
Several agents have been employed to block this nonspecific uptake 
(or adsorption), some more successfully than others--depending upon the 
tissue. Among the inhibitors used are reserpine, EDTA, and competetive 
inhibition in unlabeled NE. As outlined in Methods, vesicular preparations 
v/ere incubated with these agents. 
A. Effect of 10-^M reserpine + 3 x 10-^M EDTA (Tables 6 and 7)• 
Virtually no heart pellet could be retrieved from the preparation 
incubated with reserpine and EDTA. Similarly, pellets from kidneys 
incubated v/ith reserpine and EDTA v/ere smaller than controls. Were It 
h 
not for this observation, one might have concluded that 10- M reserpine 
+ 3 x 10“ M EDTA inhibited nonspecific uptake in the kidney by 99.14 per 
cent. The control study revealed 5.66 per cent and 1.31 per cent uptake 
by kidney and heart, respectively, at b°C. 
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Tissue Rat# Wt. of tissue Concentration Cone. 3H-NE % non-specific 
(g) 3H-NE - Fr V Fr IV uptake 
(mue/g)* (mue/g)** V/(V + IV) 
Kidney 1 1*7536 318 10043 3.1 
2 1*5020 391 9964 3.8 
3 1*3708 385 10199 3.7 
Heart 4 0.7619 68 432 13.0 
-i 
♦Granular Fraction V after passage over alumina 
♦♦Supernatant Fraction I? after passage over alumina 
Table 4. Non-specific uptake, or adsorption, of 3h~NE by kidney and heart 
vesicles 
Tissue Rat# Wt of tissue 
(g) 
ras 
X X b 
Kidney 1 1.7536 96 10 9 10 
2 1.9580 87 9 8 11 
3 2.0002 93 8 7 8 
4 1.5850 86 10 10 11 
5 1.6100 93 7 8 8 
6 1.8085 92 12 7 8 
7 1.7860 85 10 10 9 
8 1.7230 93 9 8 8 
9 1,5020 86 9 l6 8 
10 1.3708 90 8 8 9 
Heart 2 0.7619 93 8 5 5 
Standard* 1 140 60 60 4 
2 150 64 65 6 
3 130 64 63 3 
♦Standard 1,2,3* 1000 ng DL-NE applied to three columns so that % recovery 
of NE off columns could be calculated 
Table 5* Fluorometric assay of endogenous NE content of neuronal vesicles 
from rat kidney and heart 

Tissue Rat# Wt. tissue 
(g) 
3h-NE Fr V 
(muc/g) 
3h-NE Fr IV 
(muc/g) 
$ uptake 
v/(v + IV) 
Avg. £ 
uptake 
1 0.?8 594 7583 0.073 
2 0.79 344 7289 0.045 
Kidney 3 0.77 514 710? 0.067 5.66 
4 0.75 460 7573 0.057 
5 0.72 418 7630 0.052 
6 0.85 346 7279 0.045 
1 0.30 60 8861 0.007 
2 0.30 36 8833 0.004 
Heart 3 0.26 120 8442 0.014 1.31 
4 0.26 103 8226 0.012 
5 0.23 268 8444 0.031 
6 0.29 97 8824 0.011 
Table 6. Control, Uptake of -%-NE in the absence of reserpine and EBTA 
Tissue Rat# Wt. tissue 3H-NE Fr V 3h~NE Fr IV ^uptake Avg, % 
(g) (muc/g) (muc/g) v/(v + IV) uptake 
1 0.?4 47 7718 0.006 
2 0.80 47 7683 0.006 
Kidney 3 0.82 67 7572 0.009 0.86 
4 0.79 58 7383 0.008 
5 0.77 75 7760 0.010 
6 0.85 102 7652 0.013 
1 0.25 9 6330 0.000 
2 0.34 11 9173 0.000 
Heart 3 0.27 15 9743 0.000 0.00 
4 0.24 4 8995 0.000 
5 0.30 26 9274 0.000 
6 0.29 11 9438 0.000 
Table ?• Experimental. Uptake of 
and 3 X 10-3M EDTA 
'H-NE in the presence 
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From this experiment, it was concluded that either reserpine or 
EDTA or both destroyed the vesicles or dramatically altered their 
sedimentation properties. 
B. Effect of competitive inhibition with unlabeled ME (1.46 x 10-^M) + 
3 x ,0-3m EDTA (Tables 8 and 9): 
In view of the above findings, a similar experiment was performed 
using EDTA as a noncompetitive inhibitor and unlabeled ME as a competitive 
inhibitor. Pxesults are portrayed in Tables 8 and 9• 
Again, no heart pellet was obtained from the preparation incubated 
with EDTA. Clearly, this chelating agent plays a role in either the 
destruction of vesicles or alteration of their sedimentation characteristics. 
As in the above experiment, the average uptake at 4°C of ^H-NE by kidney 
and heart controls was 5-75 per cent and 0.92 per cent respectively. 
c 
C. Effect of competitive inhibition with unlabeled ME alone--2.8 x 10- M, 
1.1 x IO-^Mj 1*2 x 10-^M (Tables 10 and 11): 
The data show no significant competitive inhibition by ME of 
3 
vesicular nonspecific uptake of H-ME. 
These experiments indicated that kidney and heart granules are 
3 
capable of either passively or actively adsorbing small amounts of H-ME. 
Furthermore, efforts to block this phenomenon were unsuccessful. V/i th 
this in mind, the decision was made to proceed with turnover experiments. 
However, the results obtained would have to be interpreted in light of 
this finding. 
V. Turnover of catecholamine in rat heart and kidney 
Several preliminary experiments indicated that the concentration of 
3H-NE taken up by renal sympathetic neurons following iv. administration 
declined with time. These impressions led to the formal turnover 
experiment described in Methods. 
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Tissue Hat# Wt. tissue 3H-NE Ft V %~NE Fr XV 
(g) (mue/g) (muc/g) 
$ uptake 
V/(V + IV) 
Avg. $ 
uptake 
1 0.71 436 6880 0.059 
Kidney 2 0.69 463 7000 0.062 5.75 
3 0.70 373 6980 0.050 
1 0.27 91 21800 0.004 
Heart 2 0.32 166 17900 0.009 0.92 
3 0.32 270 18200 0.014 
Table 8 . Control. Uptake of 3H-NE in .the absence of EDTA (3 X 10* -3k) 
and unlabeled NE (1.46 X 10* "&M) 
Tissue Rat# Wt. tissue 3h~NE Fr V 3H-NE Fr IY % uptake Avg, $ 
(muc/g) (muc/g) ¥/(¥ ♦ IV) uptake 
1 0.78 81 6520 0.012 
Kidney 2 0.73 90 7290 0.012 1,28 
3 0.68 118 2830 0,014 
1 0.29 0 20750 0,000 
Heart 2 0.23 0 27500 0.000 0.00 
3 0.33 0 17550 0.000 
Table 9. 
3 
Experimental. Uptake of ^H«NE by vesicles in the presence of 
3 X 10-3m EDTA and unlabeled NE (1.46 X 10 &) 
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Tissue Rat# Wt, tissue Cone. 3H-NE Ft V 3h-NE Ft* IV uptake % Avg$ " 
(g) DL-NE (mue/g) (muc/g) V/ (V + IV) uptake 
1 0.74 0.00M 423 5950 0.006 
2 0.7? 401 5920 0.063 
3 0.82 320 5440 0.055 
4 0.82 213 4960 0.041 
Kidney 5 0.90 176 5360 0.032 4.51 
6 0.95 173 4365 0.038 
7 0.77 204 6620 0.030 
8 0.7? 255 5450 0.044 
9 0.?4 222 5960 0.036 
1 0.28 0.00M 154 18050 0.008 
2 0.27 72 18300 0.004 
3 0.30 43 17950 0.002 
4 0.34 51 16930 0.003 
Heart 5 0.30 132 15900 0.008 0.60 
6 0.34 112 14500 0,008 
7 0.35 109 17050 0,006 
8 0.3? 119 13550 0,009 
9 0.28 137 22090 0.006 
Table10 • Control, Non-soecifie uptake of -^H-NE by vesicles in absence of 
competitive inhibition by unlabeled NE 
Tissue Rat# Wt. tissue Cone. 3H-NE Ft ¥ 3h-NE Ft IV uptake $ Avg % I 
(g) DL-NE (muc/g) (muc/g) V/(V + IV) uptake 
1 0.80 2.8x10“^ 340 5590 0.056 
2 0.70 428 6830 0.059 5.70 
3 0.87 k 313 5150 0.05? 
4 0.?9 1.1x10"* 217 5350 0.039 
Kidney 5 0.82 263 6080 0.041 4.10 
6 0.98 3 198 4385 0.043 
7 0o?6 1.2x10"^ 151 5920 0.025 
8 Qo82 159 5240 0.029 2.60 
9 0.6? 165 6520 0.025 
1 0.30 2.8x10“- 142 18000 0.00? 
2 0o26 82 19660 0.004 1.20 
3 0.27 j, 16 19700 0.001 
4 0.29 l.lxlQ"4 76 17650 0.004 
Heart 5 0.26 128 19230 0.006 0.50 
6 0.28 119 18860 0.006 
7 0.34 1.2xl0“3 ?3 17200 0.004 
8 0.33 53 15200 0.003 0.30 
9 0.28 16 19130 0.001 
Table 11, Experimental. Competitive inhibition of non-specific vesicular 
uptake of ^H-NE by unlabeled NE 
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A. Table 12 supplements the experimental desiqn described in 
3 
Methods, vis-a-vis weights of animals, organs, and volume of H-NE 
inj ected. 
B. Table 13 presents the raw turnover data from which kinetic 
parameters are derived. 
C. From the information provided in Table 13, the mean (x)> 
standard deviation (SD), and standard error (SE) , with respect to concen¬ 
tration of ^H-NE, has been calculated as a function of time. Tables 
14-18. 
D. Calculation of the statistical siqnificance of decline in 
3 
concentration of H-NE as a function of time. Table 19. 
The statistical significance of decline in concentration of ^H-NE 
with respect to time, for each preparation, was ascertained by determining 
a coefficient of correlation. The results indicate that except for the 
heart vesicles (Hv), there appears to be a significant r-value for each 
preparation. This is more clearly represented by constructing linear least 
square lines. Figures 3-7. In each figure two lines of regression are 
plotted: one determined from the concentration of H-NE before passage 
over alumina; and one determined following passage over alumina. In 
addition, x * 2SE is included for each time point. The fractional turn- 
over, turnover time, and half-life of H-NE for each preparation are 
included in Table 20. 
From the coefficients of correlation, lines of regression, and the 
kinetic parameters derived therefrom, a number of observations can be 
made. 
(1) It is clear that the heart vesicular preparation did not 
adequately reflect turnover. In all likelihood, this is in part due to 
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Rat# Wt, Rat 
(g) 
K * K ** w tif V Vol. 3h-HE® 
(ec) 
1 149 0*66 Q065 0.26 0.26 0.15 
2 150 Q062 Q.6l 0.21 0.22 0.15 
3 145 0.59 0.6o 0.23 0.24 0.14 
4 146 0*56 0*58 0.21 0.23 0.15 
5 142 0*56 0,52 0.23 0.20 0.14 
6 13? 0*51 0*51 0.22 0.21 0.14 
7 155 0o?0 0.?1 Qo23 0.27 0.15 
8 140 0*58 0*56 0.24 0.22 0.14 
9 144 0.58 0*57 0.20 0.23 0.14 
10 158 0*75 0.75 0.29 0.25 0.16 
11 142 0*54 0*56 0.21 0.27 0.14 
12 169 0.69 0.74 0.2? 0.31 0.17 
13 160 0*66 0*64 0.25 0.29 0.16 
14 137 0*57 0*53 0,22 0.25 0.14 
15 145 0.60 0.62 0.2? 0.28 0.14 
16 138 0*58 0.56 0.23 0.29 0.14 
17 14? 0.6? 0.66 0.28 0.26 0.15 
18 157 O.63 O06? 0,27 0.25 0.16 
19 143 0.71 0*66 0.26 0.26 0.14 
20 138 0.58 0.60 0o23 0.24 0.14 
K* : Weight (g) of the kidney processed in 0.4N HC1C4 immediately following 
extirpation (referred to as ’'perchlorate kidney®*) 
Ky** : Weight (g) of the kidney from which granules were obtained 
: Weight (g) of the portion of heart processed in Q.4N HCXO4 immediately 
following extirpation (referred to as ’’perchlorate heart”) 
: Weight (g) of the portion of heart from which granules were obtained 






Before alumina After alumina 
Heart 




Hj. H Kv 
Kidney 
K Xs 
20 i 1534 5198 80 864 608 1298 3468 70 255 128 
19 100? 3530 63 615 438 742 242? 56 152 78 
18 677 2768 31 415 312 696 2180 26 87 35 
17 886 3854 86 768 489 804 2633 70 233 106 
16 888 3993 51 548 428 76l 2745 40 142 75 
15 3 559 2462 24 142 82 441 1744- 21 52 26 
14 579 3167 50 283 132 741 1938 45 118 53 
13 642 2672 29 164 103 876 1667 22 58 28 
12 554 2598 24 153 76 470 1558 22 59 26 
11 420 206? 32 174 105 .. 628 1355 26 64 .36 
10 7 530 1547 30 98 53 424 1317 27 70 30 
9 677 1972 23 100 56 470 1425 22 60 26 
8 468 1479 20 84 52 446 1044 18 44 23 
7 894 2040 25 11? 62 1061 1464 24 81 29 
6 877 2985 30 156 100 809 2419 32 .. 78  39 
5 12 559 1678 16 ~ur 40 548 1082 13 48 20 
4 924 2359 17 88 40 1014 1502 16 41 17 
3 421 1827 9 59 28 491 1095 8 26 9 
2 651 2194 23 109 54 768 1339 18 50 20 
1 382 1414 10 51 29 400 930 11 27 10 
Hv : refers to the concentration of ^H-NE (muc/g) in the heart vesicular preparation 
(Fr M) 
H : refers to the concentration of -%-NE (muc/g) in the heart perchlorate prep* 
: refers to ^H-NE (muc/g) in the kidney vesicular preparation (Fr M) 
K s refers to ^H-NE (muc/g) in the kidney perchlorate preparation 






X SD SE x + 2SE x - 2SE 
0.5 998 322 144 1286 710 
Before 3.0 550 81 36 622 478 
Alumina 7.0 689 194 87 863 515 
12.0 58? 216 97 781 393 
0.5 860 24? 111 1082 638 
After 3.0 631 183 82 795 467 
Alumina 7.0 642 282 126 894 390 
12.0 644 24? 110 864 424 
le 14. Heart vesicles (values in terms of muc/g) 
Time 
(hrs) 
X SD SE *x # 2SE x - 2SE 
0.5 3868 881 395 4658 3078 
Before 3.0 2593 396 177 294? 2239 
Alumina 7.0 2004 601 269 2542 1466 
12.0 1894 383 171 2236 1552 
0.5 2690 484 217 3124 2256 
After 3.0 1652 216 97 1846 1458 
Alumina 7.0 1533 521 233 1999 106? 
12.0 1189 227 102 1393 985 
Table 15. Heart - perchlorate (values in terms of mue/g) 
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Time (hrs) X SD SE x + 2SE x - 2SE 
0o5 62 22 10 82 42 
Before 3.0 32 11 •5 42 22 
Alumina 7o0 25 4 2 29 22 
12.0 15 6 3 21 9 
0.5 52 19 9 70 34 
After 3.0 2? 10 4 35 - 19 
Alumina 7.0 25 5 2 29 21 
12o0 13 4 2 17 9 
Table l6. Kidney vesicles ( values in terms of nrac/g) 
Time 
(hrs) 
X SD SE x + 2SE x - 2SE 
0.5 64-2 177 79 800 484 
Before 3.0 183 57 25 233 133 
Alumina ?oQ 111 2? 12 135 8? 
12o0 74 23 10 94 54 
0.5 173 69 31 235 111 
After 3.0 70 2? 12 94 46 
Alumina ?.0 66 15 7 80 52 
12.0 38 11 5 48 28 
Table 17. Kidney perchlorate (values in terms of muc/g) 
Time 
(hrs) 
X SD SE x * 2SE x - 2SE 
0o5 455 10? 48 551 359 
Befire 8.0 99 22 10 119 79 
Alumina 64 20 9 82 46 
12.0 38 10 5 48 28 
0.5 84 35 16 116 52 
After 3.0 33 12 5 43 23 
Alumina ^.0 29 6 3 35 23 
12.0 15 5 3 21 9 
Table 180 Kidney supernatent (values in terms of mue/g) 
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Preparation Coefficient of Correlation(r) 
Heart vesicles -0.4194 
Heart perchlorate -0.7362 
Before Kidney vesicles -0.8319 
Alumina Kidney supernatant -0.877? 
Kidney perchlorate -0.873? 
Heart vesicles -0.2863 
Heart perchlorate -0.7755 
After Kidney vesicles -0.8123 
Alumina Kidney supernatant -0.7291 








Heart vesicles (H^) 3o22 31.06 21.52 
Heart perchlorate (H) 5.68 17.60 12.20 
Before Kidney vesicles (K_) 10.63 9.41 6.52 
Alumina Kidney perchlorate(K) 15.6? 6.38 4.42 
Kidney supernatant(Ks) 17.49 5.72 3.96 
Heart vesicles 2.16 46.30 32.08 
Heart perchlorate 6.09 16.42 11.38 
After Kidney vesicles 9.95 10.05 6.96 
Alumina Kidney perchlorate 10.44 9.58 6.64 
Kidney supernatant 14.85 6.73 4.67 



















































































a poor yield of vesicles resultinq from the process of differential 
centrifugation. It should be recalled that only one-half a heart was 
used to obtain granules. 
(2) In terms of catecholamine turnover in the heart (employing the 
perchlorate preparation), these results coincide closely with those 
obtained by other workers using similar methods. This lends some 
credibility to the validity of the experimental procedure. 
(3) The lines of regression calculated from the kidney perchlorate 
preparation raise a number of important points. Before passage over 
alumina, the regression line does not fall within 2SE of the mean for two 
time points (3 and 7 hours), and barely within 2SE of the mean for the 
first time interval (one-half hour). Indeed, there appears to be a rapid 
3 
fall off in H-ME concentration within the first 3 hours, followed by a 
slower decline thereafter. 
A two component line is suggested. The first component appears to 
include events from 0 to 3 hours; while the second component reflects 
subseauent turnover. The reason for this may be as follows: V/ithin a 
short time after injection of ^H-NE, unincorporated catecholamine as 
well as labeled O-methylated catabolites collect in the urine. V/hen rats 
are sacrificed one-half hour post-inject ion, and the kidneys homogenized 
in perchlorate, much of this contamination has not yet been excreted. 
This contributes to radioactivity measured by scintillation spectrometry. 
3 
However, within 3 hours following H-ME administration, most of these 
catabolites and unincoroorated ~’H-NE have been excreted. 
Purification with alumina eliminates radioactive counts not emanatinq 
3 3 
from H-NE. The apparent concentration of incorporated H-ME thus falls 
at time = one-half hour. And the only variable which may spuriously 
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elevate this quantity is unincorporated H-NE. Support for this aroument 
is implied by the line of repression determined after alumina. Here, 
the line falls v/ithin 2SE's of the mean for each time point. 
The above observations suggest two recommendations for future 
turnover experiments using the kidney perchlorate preparation. First, 
the regression line should be calculated only from data obtained after 
passage over alumina. Second, turnover should be measured beginning 
3 
2 to 3 hours following iv. injection of H-NE. 
Figure 8 represents a recalculation of the line of regression for 
the kidney perchlorate preparation, after alumina, based on time points 
3, 7, and 12 hours. The fractional turnover, turnover time, half-life, 
and coefficient of correlation are 6.55 per cent/hour, 15.26 hours, 10.57 
hours, and 0.65, respectively. 
(4) Regression lines for turnover in the kidney vesicles and super¬ 
natant may also be broken down into two components. Rapid fall off in 
3 
concentration of H-NE appears to occur in the first 3 hours, followed 
by a slower decline. However, in the vesicular preparation, the first 
component does not represent as fast a decline in ^H-NE as its perchlorate 
analog. Nonetheless, the same explanation of the phenomenon used for the 
perchlorate preparation pertains here. 
In Figure 8 are the lines of regression for turnover in vesicles 
3 
and supernatant, respectively, based on H-NE concentration at times 3, 
7, and 12 hours (after alumina). Fractional turnover, turnover time, half- 
life, and coefficient of correlation for these lines are summarized in 
Table 21. In future turnover experiments using a vesicular preparation, 
the same recommendations apply as those outlined in (3) above. 






















k = 8.84% / hr 











Kidney perchlorate (K) 6.55 15o26 10.57 - 0.6555 
Kidney supernatant (K ) 8.84 11.30 7.84 - 0.7542 
Kidney vesicles (K^) 7.83 12.77 8.85 - 0.7293 
* decline ^H-NE (muc/g) per hour 
Table 21. Kinetic parameters derived from regression lines recalculated for 
time: 3, 7» 12 hrs. (after passage over alumina) 
Comparison of 
Regression Lines 
t - value p - value 
Kidney vesicles (Kv) 
vs. 
Kidney perchlorate (K) 
0.474 p<0.?0 
Kidney vesicles (Ky) 
vs. 
Kidney supernatant (Ks) 
O.36O p< 0.80 
Kidney perchlorate (K) 
vs. 
Kidney supernatent (Kg) 
0.803 P< 0.50 
Table 22. Comparison of slopes of regression lines recalculated for time: 3, 7, 
and 12 hrs. (after passage over alumina). 

of regression (after alumina) for turnover in the kidney vesicular and 
perchlorate preparations. This was revealed by determining the standard 
error of estimate about each line, and using this to compare slopes by 
the standard t-test. Table 22. Hence, it may be argued that one need 
not prepare vesicles via the arduous procedure of differential centrifu¬ 
gation In order to measure turnover of catecholamine. Instead, the 
perchlorate preparations are adequate in this regard, after passage over 
a Ium ina. 
VI. Effect of ganglionic blockage on catecholamine turnover 
During periods of sympathetic ganglionic blockage, one would anticipate 
less adrenergic activity in end-organs. Consequently, there should be 
less turnover of catecholamine In sympathetic nerve endings. Under these 
conditions, ^H-NE which is taken up by sympathetic nerves, and stored in 
vesicles, should enjoy a longer half-life than it does under normal circum¬ 
stances. In this experiment (see Methods) ch1 orisondamine hydrochloride 
(Ecolid) was employed as the ganglionic blocking agent. It Is of interest 
that those animals which received Ecolid demonstrated, quite dramatically, 
the extra-renal manifestations of ganglionic blockade: extreme ptosis and 
bladder distension. 
A. Table 23 illustrates the pertinent data relative to the experimental 
set-up. 
B. Concentration of JH-NE, 6 hours after iv. administration of this 
isotope, is presented for chlorisondamine-treated and control animals. 
Table 2k. 
C. For each preparation, the mean (x)> standard deviation (SD), and 
standard error (SE) were determined for ^H-NE concentration, Table 25, 
(after alumina). These results are graphically portrayed in Figure 3. 
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D. Conclusions: That ch1 orisondamine significantly retards the 
turnover of catecholamine is readily apparent In Figure 9. This is 
confirmed by comparing control and chlorisondamine-treated groups by 
standard t-test, Table 26, Pharmacologic evidence has thus been adduced 
in support of the conclusion derived from the previous turnover experiment 
that turnover of catecholamine does exist In the kidney. 
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Rat # Wt. of rat(g) Wt* of kidneys (g) Wt. of heart (g) 
1 215 1.46 0.62 
2 202 1.52 0.60 
3 200 1.42 0,62 
4 190 1.45 0.56 
5 18? 1.36 0.52 
6 214 1.84 0.?0 
7 195 1.63 0.54 
8 202 1.60 0.62 
9 192 1.54 0.57 
10 204 1.50 0.60 
11 205 1.39 0.55 






H K K v s 
After Alumina 
Heart Kidney 
H K K V ft 
2 2799 37 86 4722 40 4? 
4 2642 35 85 4892 38 42 
Control 6 3597 57 103 5970 6? 58 
8 2853 43 97 5054 42 42 
10 2567 51 8? 3515 58 54 
12 2566 39 79 4146 50 39 
1 3640 101 111 5983 94 83 
* 
3 4130 111 132 5802 122 109 
Eeolid 5 3365 97 135 5717 92 115 
7 3833 124 134 7264 71 112 9 3958 104 104 7197 77 88 
11 4712 72 101 7182 70 74 
H s heart perchlorate preparation; nrae -%-NE/g 
Kv ; kidney vesicular preparation; mue ^H-NE/g (Fraction V. ) 
Ks J kidney supernatant preparation; mue 3{f»NE /g (Fraction IV.’) 
Table 24, 
Preparation "x SD SE x * 2SE "x - 2SE 
Heart 4716 834 342 5400 4032 
Control \ * 49 11 4 57 41 
Ks ** 47 7 3 53 41 
Heart 6524 761 312 7148 5900 
Eeolid Kv 87 19 8 103 71 
Ks 96 17 7 110 82 
* : Kidney vesicles (Ft* VI) 
** : Kidney supernatent (Fi* IV';) 




Preparation t-value p-v&Xue 
Heart 4.04 p< 0.005 
Kidney vesicles 4.25 p< 0.005 







The experimental results presented in this paper support the 
contention that catecholamine turnover in the kidney exists and can be 
measured. Methods employed in obtaining this information were predicated 
upon the principles of steady state kinetics. Conclusions derived from 
this analysis were corroborated by the demonstration that sympathetic 
ganglionic blockade significantly retards catecholamine turnover. 
In the conduct of this research, however, a few problems were encountered 
which have some bearing on the interpretation of the experimental results. 
For example, the endogenous assay of NE, as described by von Euler and 
Lishajake, was frustrated by the presence of a nonproteinaceous contaminant 
in the kidney. This was not present in rat heart or urine. Addition of 
a Dowex cation exchange column to the standard method alumina chromatography 
did not prove of value in overcoming this problem. Hence, adrenergic 
activity was. guant i f i ed in terms of m>ic H-NE per gram of kidney tissue. 
The assumptions upon which this unit of measurement is based are elaborated 
in Materials and Methods. Clearly, this is not as significant a measure¬ 
ment of sympathetic tone as specific activity would have been (mjjc ^H-NE/ 
ng ME). In future experiments, one may approach this problem by determining 
endogenous ME via a recently developed enzyme radiochemical assay for NE. 
Another problem which defied complete resolution was an inability to 
inhibit the small amount of '5H-HE which is adsorbed by (or taken up by) 
the neuronal vesicles. This phenomenon has been described for other 
populations of vesicles and is temperature-dependent. Though unable to 
totally prevent adsorption, the process was minimized in these experiments 
by maintaining the vesicular preparations at h°C. It should also be 
mentioned that in the course of investigating this problem, EDTA was found 
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to either destroy or dramatically alter the sedimentation properties 
of rat heart and kidney granules. 
One additional criticism may be leveled against the turnover experiments 
performed here. Only five rats comprised each time interval. To have 
used more animals would have proved exceedingly difficult, given the 
facilities available to the author for isolating granules. Ideally, one 
would require far more than this number in order to minimize the standard 
error which derives from the biological variation of such a small group. 
A finding of significant relevance to this problem is the lack of 
statistical difference between the regression lines obtained from kidney 
vesicular and perchlorate preparations (after passage over alumina, a'nd 
calculated for time 3, 7, 12 hours). The implication of this is obvious: 
turnover in the kidney may be measured usinc the perchlorate perparation, 
as is done with the heart. Thus, the need to isolate vesicles by the 
arduous procedure of differential centrifugation is obviated. One could 
then easily include ten or more rats per time interval, and thereby 
improve the statistical significance of the results. 
What other experiments might be conducted to lend further support 
for the conclusions reached from this research? One exciting possibility 
involves the use of 6-hydroxydopamine. In high doses, this agent produces 
degenerative lesions in terminal adrenergic fibers, comparable to those 
produced after surgical denervation (7A). Within 1-2 hours following 
intravenous injection of 6-hydroxydopamine (100 mg/kg) into rats, endogenous 
NE of the heart declines 70-90 per cent. This catecholamine depletion 
persists for weeks, and slowly returns thereafter, along with regeneration 
of the adrenergic terminal fiber plexus. 




demonstrate that iv. administered H-NE is incorporated into the 
sympathetic neuronal granules of the kidney. Just prior to administration 
3 
of H-NE, experimental animals would be given 6-hydroxydopam?ne iv. 
(100 mg/kg). Controls would receive saline. Six to eight hours following 
injection of "H-NE, animals would be sacrificed and kidney and heart 
perchlorate preparations obtained. One would expect to see a much 
3 
diminished concentration of JH-ME in tissue from rats treated with 6-hydroxy- 
dopamine, compared with controls. 
Such experiments have already been conducted Sn the laboratory of 
Dr. Lewis Landsberg at Boston City Hospital (personal communication). 
His results are in accordance with the expectations discussed above. 
Having established that renal catecholamine turnover exists and can 
be quantified, researchers may direct their efforts toward correlating 
sympathetic activity with changes in sodium metabolism, using the methods 
worked out here. These investigations could provide much needed insight 
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